Literature DB >> 31254795

The currently declining incidence of cancer of unknown primary.

Elie Rassy1, Nicholas Pavlidis2.   

Abstract

Cancer of unknown primary (CUP) is a heterogeneous group of metastatic cancers for which a primary tumor cannot be identified after a standardized work-up. The biology of CUP has not been fully elucidated and epidemiologic data may be helpful in this regard. The variations in the incidence-rate over time and between countries reflect changes in the risk factors for CUP, incidence trends of the primary tumors that potentially contribute to the burden of CUP and changes in the diagnostic technologies and practice. CUP accounted for 3-5% of cancers in the historical series but its incidence seems to decline in the recent publications. This paper reviews the published cancer-registry studies in order to identify and understand the variations in the incidence-rates of CUP.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CUP; Cancer of unknown primary; Epidemiology; Incidence

Mesh:

Year:  2019        PMID: 31254795     DOI: 10.1016/j.canep.2019.06.006

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  16 in total

Review 1.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

2.  Nationwide survey on family caregiver-perceived experiences of patients with cancer of unknown primary site.

Authors:  Kyoko Ishida; Kazuki Sato; Hirokazu Komatsu; Tatsuya Morita; Tatsuo Akechi; Megumi Uchida; Kento Masukawa; Naoko Igarashi; Yoshiyuki Kizawa; Satoru Tsuneto; Yasuo Shima; Mitsunori Miyashita; Shoko Ando
Journal:  Support Care Cancer       Date:  2022-04-28       Impact factor: 3.603

3.  Cancer-of-Unknown-Primary-Origin: A SEER-Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice.

Authors:  Linda Mileshkin; Tilmann Bochtler; Gemma Gatta; Razelle Kurzrock; Andreas Beringer; Mathis Müller-Ohldach; Andy Surinach; Camille Perret; Marlene Thomas; Adam Gondos; Alwin Krämer
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

Review 4.  What can we learn from cancer of unknown primary in canine oncology?

Authors:  Aline Khazzaka; Elie Rassy; Nicholas Pavlidis
Journal:  J Adv Res       Date:  2020-06-10       Impact factor: 10.479

Review 5.  Cancer of Unknown Primary: Challenges and Progress in Clinical Management.

Authors:  Noemi Laprovitera; Mattia Riefolo; Elisa Ambrosini; Christiane Klec; Martin Pichler; Manuela Ferracin
Journal:  Cancers (Basel)       Date:  2021-01-25       Impact factor: 6.639

6.  The Diminishing Importance of Primary Site Identification in Cancer of Unknown Primary: A Canadian Single-Center Experience.

Authors:  Boaz Wong; Michael M Vickers; Paul Wheatley-Price
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

7.  Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer.

Authors:  Melania Costantini; Rino Aldo Montella; Maria Paola Fadda; Giorgia Garganese; Alba Di Leone; Alejandro Martin Sanchez; Gianluca Franceschini; Pierluigi Maria Rinaldi
Journal:  J Pers Med       Date:  2021-05-25

Review 8.  Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?

Authors:  Elie Rassy; Tarek Assi; Nicholas Pavlidis
Journal:  Br J Cancer       Date:  2020-02-11       Impact factor: 7.640

9.  Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP).

Authors:  Hamidreza Aboulkheyr Es; Hamid Mahdizadeh; Amir Abbas Hedayati Asl; Mehdi Totonchi
Journal:  Sci Rep       Date:  2021-07-23       Impact factor: 4.379

10.  Expression of Glycolysis-Related Proteins in Cancer of Unknown Primary Origin.

Authors:  Murilo Bonatelli; Isabella Fernandes Fornari; Priscila Neves Bernécule; Lara Esquiapatti Pinheiro; Ricardo Filipe Alves Costa; Adhemar Longatto-Filho; João Neif Antonio Junior; Eduardo Caetano Albino Silva; Flávio Mavignier Cárcano; Céline Pinheiro
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.